GL1X · GenesisL1 explorer

Research workbench

Crystal structure of SARS-cov-2 3CL in complex with inhibitor EB56

Analyse Crystal structure of SARS-cov-2 3CL in complex with inhibitor EB56 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7TIX
Type
protein
Length
302 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
3C-like proteinase NSP5
EC
3.4.22.69
UniProt
P0DTC1
Ligands
Q56, MG
Pockets
3 · best druggability 0.57

Structure

x-ray diffraction · 1 distinct chain · 25% helix, 28% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A3C-like proteinase NSP5 (EC 3.4.22.69)protein30225% helix, 28% strandP0DTC1

Ligands and binding sites

  • Q56 · N~2~-{[(naphthalen-2-yl)methoxy]carbonyl}-N-{(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-leucinamide · ligand · chains A
  • MG · Magnesium ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12130.570.7931Q56
2730.330.7518empty
3500.310.7615empty

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 7TIX · Crystal structure of SARS-CoV-2 3CL in complex with inhibitor EB56 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.